Express Scripts (NASDAQ: ESRX) reported Q2 EPS of $1.57, in-line with the analyst estimate of $1.57. Revenue for the quarter came in at $25.2 billion versus the consensus estimate of $25.42 billion.

GUIDANCE:

Express Scripts sees FY2016 EPS of $6.33-$6.43, versus prior guidance of $6.31-$6.43 and the consensus of $6.35.

For earnings history and earnings-related data on Express Scripts (ESRX) click here.